Amneal Pharmaceuticals Inc. (AMRX) |
|
6.79 -0.21 (-3%)
|
06-19 16:02 |
|
Open: |
7.01 |
Pre. Close: |
7 |
|
High:
|
7.05 |
Low:
|
6.55 |
|
Volume:
|
2,500,982 |
Market Cap:
|
2029M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
7.038 - 7.075 |
7.075 - 7.107 |
|
Low:
|
6.486 - 6.526 |
6.526 - 6.56 |
|
Close:
|
6.722 - 6.792 |
6.792 - 6.852 |
|
Technical analysis |
as of: 2019-06-19 4:29:12 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 9.79 One year: 11.10 |
| Support: |
Support1: 6.57 Support2: 5.47 |
| Resistance: |
Resistance1: 8.38 Resistance2: 9.50 |
| Pivot: |
7.48 |
| Moving Average: |
MA(5): 6.98 MA(20): 7.67
MA(100): 11.79 MA(250): 15.92 |
| MACD: |
MACD(12,26): -0.90  Signal(9): -0.98 |
| Stochastic oscillator: |
%K(14,3): 11.30 %D(3): 8.88 |
| RSI: |
RSI(14): 26.33 |
| 52-week: |
High: 24.48 Low: 6.57 Change(%): -62.7 |
| Average Vol(K): |
3-Month: 103900 10-Days: 102938 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.AMRX has closed above bottom band by 8.6%. Bollinger Bands are 38.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 05 Jun 2019 03:07:09 Z
Here's Why Generic-Drug Manufacturers Lost As Much As 43.2% in May
Tue, 21 May 2019 20:26:47 Z
Health Care Sector Update for 05/21/2019: QTNT,ARRY,AMRX,OCUL
Tue, 21 May 2019 18:07:10 Z
Health Care Sector Update for 05/21/2019: ARRY,AMRX,OCUL
Mon, 20 May 2019 13:07:10 Z
Peek Under The Hood: VB Has 14% Upside
Thu, 09 May 2019 22:58:33 Z
Amneal Pharmaceuticals, Inc. (AMRX) Q1 2019 Earnings Call Transcript
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Specialty Generic |
| Shares Out. (M) |
298.83 |
| Shares Float (M) |
298.18 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
50.00 |
|
Shares Short (K)
|
5922 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
0.820 |
|
EPS Est. Current Year
|
|
|
EPS Est. Next Year
|
|
|
EPS Est. Next Quarter
|
|
|
Forward EPS
|
|
|
Book Value (p.s.)
|
4.900 |
|
PEG Ratio
|
0.49 |
|
Profit Margin
|
-20.67 |
|
Operating Margin
|
12.84 |
|
Return on Assets (ttm)
|
-1.6 |
|
Return on Equity (ttm)
|
-14.6 |
|
Qtrly Rev. Growth
|
62.1 |
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
114.79 |
|
Levered Free Cash Flow (M)
|
195.34 |
Stock Valuations |
|
P/E
|
8.28 |
|
P/E Growth Ratio
|
-0.03 |
|
P/BV
|
1.39 |
|
P/S
|
54489748.00 |
|
P/CF
|
17.68 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
